Picture of Respiri logo

RSH Respiri Income Statement

0.000.00%
au flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

Annual income statement for Respiri, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.

2019
June 30th
2020
June 30th
2021
June 30th
2022
June 30th
2023
June 30th
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue1.032.211.440.7790.662
Cost of Revenue
Gross Profit0.1740.520.597
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Total Operating Expenses9.499.4612.47.336.42
Operating Profit-8.45-7.26-11-6.55-5.75
Total Net Non Operating Interest Income / Expense
Net Income Before Taxes-8.47-7.26-11-6.62-5.78
Provision for Income Taxes
Net Income After Taxes-8.47-7.26-11-6.62-5.78
Net Income Before Extraordinary Items
Net Income-8.47-7.26-11-6.62-5.78
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income-8.47-7.26-11-6.62-5.78
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS-0.016-0.011-0.016-0.009-0.007